- Research works
- 45 ▲ 166% vs 2013–17
- Citations
- 350 7.7 per fractional work
- Top-10% rate
- 0.9% record average 16.5%
- Open access
- 60% world 28%
Not ranked overall: STCube (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 5.3×. Every wedge is a field page.
Which keywords describe research at STCube (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Tumor Microenvironment, Cancer, Immunotherapy, Immune Checkpoint Blockade, PD-1 and PD-L1, Tumor Regression, Bacterial Therapy and Tumor Targeting.
- Coopetition
- Therapeutic Antibodies
- Clinical Trials
- Cancer Therapy
- Angiogenesis
- Glycosylation
- Tumor Targeting
- Tumor Regression
- Immune Checkpoint Blockade
- Cancer
- Tumor Microenvironment
- Immunotherapy
- PD-1 and PD-L1
- Bacterial Therapy
- Innovation
- Targeted Therapy
- Cell Proliferation
- Chemotherapy
- Fc Receptors
- Business Networks
- Stem Cells
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 21 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 21 words, with their numbers
- Tumor Microenvironment4▲ 42×5 topics
- Cancer3▲ 11×8 topics
- Immunotherapy3▲ 16×4 topics
- Immune Checkpoint Blockade2▲ 98×1 topic
- PD-1 and PD-L12▲ 98×1 topic
- Tumor Regression2▲ 86×2 topics
- Bacterial Therapy2▲ 213×1 topic
- Tumor Targeting2▲ 43×1 topic
- Innovation2▲ 6.8×3 topics
- Glycosylation2▲ 57×2 topics
- Targeted Therapy1▲ 26×5 topics
- Angiogenesis1▲ 17×4 topics
- Cell Proliferation1▲ 64×2 topics
- Cancer Therapy1▲ 8.1×4 topics
- Chemotherapy1▲ 6.7×5 topics
- Clinical Trials1▲ 6.8×3 topics
- Fc Receptors1▲ 89×1 topic
- Therapeutic Antibodies1▲ 70×1 topic
- Business Networks1▲ 224×1 topic
- Coopetition1▲ 224×1 topic
- Stem Cells1▲ 17×2 topics
Which research topics does STCube (United States) publish most on?
By volume in 2022–2025: Cancer Immunotherapy and Biomarkers, Cancer Research and Treatments, Monoclonal and Polyclonal Antibodies Research and Business Strategy and Innovation.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Immunotherapy and Biomarkers Oncology 2 works
- 2 Cancer Research and Treatments Biotechnology 2 works
- 3 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
- 4 Business Strategy and Innovation Strategy and Management 1 works
- 5 Hippo pathway signaling and YAP/TAZ Cell Biology 1 works
- 6 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 1 works
- 7 Genetic factors in colorectal cancer Pathology and Forensic Medicine 1 works
- 8 Peptidase Inhibition and Analysis Oncology 0 works
- 9 Cancer Cells and Metastasis Oncology 0 works
- 10 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has STCube (United States)'s research output changed?
Output in 2018–2022 was 166% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Gaithersburg
- National Institute of Standards and Technology
- Molecular Oncology (United States)
- Scientific Consulting Group
- NIST Center for Neutron Research
- Material Measurement Laboratory
- Center for Nanoscale Science and Technology
- Information Technology Laboratory
- Robotic Research (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.